2010
DOI: 10.1016/j.bmcl.2009.04.091
|View full text |Cite
|
Sign up to set email alerts
|

Discovery of small molecule isozyme non-specific inhibitors of mammalian acetyl-CoA carboxylase 1 and 2

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
36
0

Year Published

2010
2010
2024
2024

Publication Types

Select...
7
2

Relationship

2
7

Authors

Journals

citations
Cited by 53 publications
(37 citation statements)
references
References 8 publications
1
36
0
Order By: Relevance
“…5A) [108,174]. Structures of the human and bovine ACC2 CT domain have been reported at 3.2 Å and 2.4 Å resolution, respectively [112,175].…”
Section: Acetyl-coa Carboxylase (Acc)mentioning
confidence: 99%
“…5A) [108,174]. Structures of the human and bovine ACC2 CT domain have been reported at 3.2 Å and 2.4 Å resolution, respectively [112,175].…”
Section: Acetyl-coa Carboxylase (Acc)mentioning
confidence: 99%
“…87 Finally, it should be noted that compounds belonging to the spirochromanones class of molecules, which are structural analogs of CP-640186, were found to inhibit both isoforms of human carboxyltransferase. 88 Crystal structures of these inhibitors bound to either the carboxyltransferase domain of yeast acetyl-CoA carboxylase or the yeast nine-residue variant version demonstrated that these inhibitors likewise bind in the same site as CP-640186. 86 …”
Section: Inhibitors Of Carboxyltransferasementioning
confidence: 99%
“…Because human ACC1 and ACC2 produce two separate pools of malonyl-CoA with dramatically different functions, isozyme-specific inhibitors are highly desirable. The current arsenal of small-molecule inhibitors of mammalian ACC includes several classes of compounds with different chemical cores and submicromolar IC 50 and, in some cases, a modest isozyme specificity (22)(23)(24)(25)(26)(27). No drugs targeting human ACC have yet been developed, based on these compounds or others.…”
Section: Fatty Acid Metabolism | Human Healthmentioning
confidence: 99%